Intravenous Drug Use Rates and Results of Direct-acting Antiviral Treatment in Prisoner Patients
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 2
Abstract
Objectives: Intravenous drug use (IVDU) is more common in prisoner patients, and this is a global problem. Hepatitis C virus (HCV) infection is higher in prisoners than general population. In our study, we aimed to examine the IVDU rates and direct-acting antiviral (DAA) treatment results of the prisoners who applied to Hatay Mustafa Kemal University Clinic of Infectious Diseases. Materials and Methods: In our study, IVDU rates and HCV treatment results of 85 prisoners who applied to Hatay Mustafa Kemal University Faculty of Medicine Clinic of Infectious Diseases between January 2017 and December 2019 were retrospectively analyzed. Treatment results were evaluated by performing modified intention to tract (mITT) and per protocol (PP) efficacy analysis, respectively. Results: The rate of IVDU was 37.7% in prisoners who were positive for HCV. Although sustained virological response (SVR) rate was 100% in PP analysis, SVR rate was determined as 80.5% in mITT analysis. Viral genotype 3 (41.6%) and genotype 4 (39%) were the most common. Conclusion: However, data on HCV screening and treatment in prisons in Turkey is inadequate or too low. We think that with the use of DAAs, patients’ compliance to treatment will increase, it is an important step for HCV eradication and multicenter studies should be conducted.
Authors and Affiliations
Mehmet Çabalak, Tayibe Bal
Keywords
Related Articles
- EP ID EP688800
- DOI 10.4274/vhd.galenos.2020.2020.0015
- Views 121
- Downloads 0
Non-hodgkin Lymphoma Developing After Discontinuation of Direct-acting Antiviral Treatment for Hepatitis C: A Case Report
Today, direct-acting antivirals (DAA) are the main treatment options for hepatitis C infection. However, whether malignancy risk is increased after DAA treatment is a matter of debate. Conflicting results have been repor...
The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
Objectives: Directly-acting anti-viral agents for the treatment of hepatitis C have been revolutionised. In the meantime, hepatitis C patients with sustained virologic response (SVR) achieved with previous treatments hav...
The Evaluation of a Hundred Eleven Adult Patients with Acute Hepatitis
Objectives: We aimed to evaluate the etiological, epidemiological and laboratory characteristics of adult patients admitted to our hospital with acute hepatitis. Materials and Methods: The patients with alanine aminotra...
An Evaluation of the Efficacy of High-dose Hepatitis B Vaccine in Patients Using Biological Agents
Objectives: Hepatitis B virus (HBV) vaccination is efficient in the normal population, whereas lower humoral response rates in immunosuppressed patients. Biological agents used in the treatment of several diseases in rec...
Age Specific Hepatitis B Surface Antigen (HBsAg) and Anti-HBs Seroprevalence among Patients Admitted to a State Hospital
Objectives: Chronic hepatitis B (CHB) infection affects 257 million people globally, Turkey is middle endemic region. According to public health data, about 2 million people in Turkey are considered to be positive for he...